The store will not work correctly when cookies are disabled.
5-chloro-2-(3-(trifluoromethyl)phenyl)-2,3-dihydroquinazolin-4(1H)-one
ID: ALA5203878
PubChem CID: 164880771
Max Phase: Preclinical
Molecular Formula: C15H10ClF3N2O
Molecular Weight: 326.70
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1NC(c2cccc(C(F)(F)F)c2)Nc2cccc(Cl)c21
Standard InChI: InChI=1S/C15H10ClF3N2O/c16-10-5-2-6-11-12(10)14(22)21-13(20-11)8-3-1-4-9(7-8)15(17,18)19/h1-7,13,20H,(H,21,22)
Standard InChI Key: NVZDEYSWTGQBOV-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
-3.2152 -0.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4984 -0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7878 -0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 -0.6197 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 -0.2068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3577 0.6188 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 1.0316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7878 0.6188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5002 1.0309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2152 0.6184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0728 1.8574 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 -0.6197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3573 -1.4489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0743 -1.8574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7850 -1.4452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7850 -0.6192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0725 -0.2070 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5002 1.8567 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 -0.2064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5001 0.6192 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2152 -0.6192 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.2152 0.2063 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
8 7 1 0
3 8 2 0
8 9 1 0
9 10 2 0
10 1 1 0
7 11 2 0
5 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 12 2 0
9 18 1 0
16 19 1 0
19 20 1 0
19 21 1 0
19 22 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 326.70 | Molecular Weight (Monoisotopic): 326.0434 | AlogP: 4.21 | #Rotatable Bonds: 1 |
Polar Surface Area: 41.13 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.33 | CX Basic pKa: ┄ | CX LogP: 4.53 | CX LogD: 4.53 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.82 | Np Likeness Score: -1.17 |
References
1. Shishodia S, Nuñez R, Strohmier BP, Bursch KL, Goetz CJ, Olp MD, Jensen DR, Fenske TG, Ordonez-Rubiano SC, Blau ME, Roach MK, Peterson FC, Volkman BF, Dykhuizen EC, Smith BC.. (2022) Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening., 65 (20.0): [PMID:36227159] [10.1021/acs.jmedchem.2c00864] |